Goserelin (Zoladex®) in the treatment of fibroids
- 1 February 1992
- journal article
- review article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 99 (s7) , 27-30
- https://doi.org/10.1111/j.1471-0528.1992.tb13536.x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Treatment with GnRH agonists before myomectomy and the risk of short-term myoma recurrenceBJOG: An International Journal of Obstetrics and Gynaecology, 1990
- Epidermal growth factor in urine of pregnant women and in amniotic fluid throughout pregnancyGynecological Endocrinology, 1990
- The binding of steroids to myometrium and leiomyomata (fibroids) in women treated with the gonadotrophin-releasing hormone agonist Zoladex (ICI 118630)Journal of Endocrinology, 1989
- The binding of epidermal growth factor to the human uterus and leiomyomata in women rendered hypooestrogenic by continuous administration of an LHRH agonistBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- Binding Sites for Epidermal Growth Factor in Human Uterine Tissues and LeiomyomasJournal of Clinical Endocrinology & Metabolism, 1984
- A conservative approach to the management of uterine leiomyoma: Pituitary desensitization by a luteinizing hormone-releasing hormone analogueAmerican Journal of Obstetrics and Gynecology, 1983